EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Empagliflozin after Acute Myocardial Infarction

Javed Butler, W Schuyler Jones, Jacob A Udell, Stefan D Anker, Mark C Petrie, Josephine Harrington iD, Michaela Mattheus, Isabella Zwiener, Offer Amir, M Cecilia Bahit, Johann Bauersachs, Antoni Bayes-Genis und 29 weitere

New England Journal of Medicine · 25.04.2024 · 390 (16) · 1455-1466

DOI: 10.1056/nejmoa2314051 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 25.04.2024. Verfasst von Javed Butler und 40 weiteren Autor:innen. Beteiligte Einrichtung: From Baylor Scott and White Research Institute, Dallas (J. Butler); the Department of Medicine, University of Mississippi, Jackson (J. Butler); the D…. Hauptthemen laut MEDLINE: Heart Failure, Myocardial Infarction, Sodium-Glucose Transporter 2 Inhibitors. Die Arbeit wurde bisher 317-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Boehringer Ingelheim and Eli Lilly and Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMyocardial InfarctionSodium-Glucose Transporter 2 InhibitorsAgedFemaleHumansMaleMiddle AgedBenzhydryl CompoundsDouble-Blind MethodFollow-Up StudiesGlucosidesHospitalizationKaplan-Meier EstimateTreatment OutcomeHeart Disease Risk Factors

Substanzen

Benzhydryl CompoundsempagliflozinGlucosidesSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • From Baylor Scott and White Research Institute, Dallas (J. Butler); the Department of Medicine, University of Mississippi, Jackson (J. Butler); the Division of Cardiology, Department of Medicine, Duke University Medical…

ORCID-Profile: Josephine Harrington, Tomasz Gasior, Xavier Rossello, P Gabriel Steg

Förderung

  • Boehringer Ingelheim and Eli Lilly and Company

Zitieren

APA

Butler, J., Jones, W. S., Udell, J. A., Anker, S. D., Petrie, M. C., Harrington, J., Mattheus, M., Zwiener, I., Amir, O., Bahit, M. C., Bauersachs, J., Bayes-Genis, A., Chen, Y., Chopra, V. K., Figtree, G., Ge, J., Goodman, S. G., Gotcheva, N., Goto, S., …, & Hernandez, A. F. (2024). Empagliflozin after Acute Myocardial Infarction. New England Journal of Medicine, 390(16), 1455-1466. https://doi.org/10.1056/nejmoa2314051

Vancouver

Butler J, Jones WS, Udell JA, Anker SD, Petrie MC, Harrington J, et al. Empagliflozin after Acute Myocardial Infarction. New England Journal of Medicine. 2024;390(16):1455-1466. doi:10.1056/nejmoa2314051

BibTeX
@article{Butler2024,
  author = {Butler, Javed and Jones, W Schuyler and Udell, Jacob A and Anker, Stefan D and Petrie, Mark C and Harrington, Josephine and Mattheus, Michaela and Zwiener, Isabella and Amir, Offer and Bahit, M Cecilia and Bauersachs, Johann and Bayes-Genis, Antoni and Chen, Yundai and Chopra, Vijay K and Figtree, Gemma and Ge, Junbo and Goodman, Shaun G and Gotcheva, Nina and Goto, Shinya and Gasior, Tomasz and Jamal, Waheed and Januzzi, James L and Jeong, Myung Ho and Lopatin, Yuri and Lopes, Renato D and Merkely, Béla and Parikh, Puja B and Parkhomenko, Alexander and Ponikowski, Piotr and Rossello, Xavier and Schou, Morten and Simic, Dragan and Steg, P Gabriel and Szachniewicz, Joanna and van der Meer, Peter and Vinereanu, Dragos and Zieroth, Shelley and Brueckmann, Martina and Sumin, Mikhail and Bhatt, Deepak L and Hernandez, Adrian F},
  title = {Empagliflozin after Acute Myocardial Infarction},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {390},
  number = {16},
  pages = {1455--1466},
  doi = {10.1056/nejmoa2314051}
}
Kostenlos starten →